JP7365707B2 - ステビオール配糖体レバウジオシドｊ及びレバウジオシドｎの生合成による製造 - Google Patents

ステビオール配糖体レバウジオシドｊ及びレバウジオシドｎの生合成による製造 Download PDF

Info

Publication number
JP7365707B2
JP7365707B2 JP2020546338A JP2020546338A JP7365707B2 JP 7365707 B2 JP7365707 B2 JP 7365707B2 JP 2020546338 A JP2020546338 A JP 2020546338A JP 2020546338 A JP2020546338 A JP 2020546338A JP 7365707 B2 JP7365707 B2 JP 7365707B2
Authority
JP
Japan
Prior art keywords
seq
rebaudioside
recombinant polypeptide
amino acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020546338A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021515555A5 (enExample
JP2021515555A (ja
Inventor
グオホン マオ，
マイケル バッテン，
フィリップ ハント，
シャオダン ユー，
Original Assignee
コナゲン インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コナゲン インコーポレイテッド filed Critical コナゲン インコーポレイテッド
Publication of JP2021515555A publication Critical patent/JP2021515555A/ja
Publication of JP2021515555A5 publication Critical patent/JP2021515555A5/ja
Priority to JP2023110059A priority Critical patent/JP2023126903A/ja
Application granted granted Critical
Publication of JP7365707B2 publication Critical patent/JP7365707B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A23L27/36—Terpene glycosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01013—Sucrose synthase (2.4.1.13)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01017—Glucuronosyltransferase (2.4.1.17)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Mycology (AREA)
JP2020546338A 2018-03-12 2019-03-12 ステビオール配糖体レバウジオシドｊ及びレバウジオシドｎの生合成による製造 Active JP7365707B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023110059A JP2023126903A (ja) 2018-03-12 2023-07-04 ステビオール配糖体レバウジオシドｊ及びレバウジオシドｎの生合成による製造

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862641590P 2018-03-12 2018-03-12
US62/641,590 2018-03-12
US201862682260P 2018-06-08 2018-06-08
US62/682,260 2018-06-08
US201862695252P 2018-07-09 2018-07-09
US62/695,252 2018-07-09
PCT/US2019/021876 WO2019178116A1 (en) 2018-03-12 2019-03-12 Biosynthetic production of steviol glycosides rebaudioside j and rebaudioside n

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023110059A Division JP2023126903A (ja) 2018-03-12 2023-07-04 ステビオール配糖体レバウジオシドｊ及びレバウジオシドｎの生合成による製造

Publications (3)

Publication Number Publication Date
JP2021515555A JP2021515555A (ja) 2021-06-24
JP2021515555A5 JP2021515555A5 (enExample) 2022-02-14
JP7365707B2 true JP7365707B2 (ja) 2023-10-20

Family

ID=67908465

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020546338A Active JP7365707B2 (ja) 2018-03-12 2019-03-12 ステビオール配糖体レバウジオシドｊ及びレバウジオシドｎの生合成による製造
JP2021571495A Active JP7305213B2 (ja) 2018-03-12 2020-07-09 変異体酵素を介するステビオール配糖体レバウシオシドｉの生合成的産生
JP2023110059A Pending JP2023126903A (ja) 2018-03-12 2023-07-04 ステビオール配糖体レバウジオシドｊ及びレバウジオシドｎの生合成による製造

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021571495A Active JP7305213B2 (ja) 2018-03-12 2020-07-09 変異体酵素を介するステビオール配糖体レバウシオシドｉの生合成的産生
JP2023110059A Pending JP2023126903A (ja) 2018-03-12 2023-07-04 ステビオール配糖体レバウジオシドｊ及びレバウジオシドｎの生合成による製造

Country Status (8)

Country Link
US (4) US11447808B2 (enExample)
EP (2) EP3765627A4 (enExample)
JP (3) JP7365707B2 (enExample)
KR (1) KR20210153670A (enExample)
CN (1) CN111868252B (enExample)
BR (1) BR112021021828A2 (enExample)
MX (1) MX2021013721A (enExample)
WO (2) WO2019178116A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7365707B2 (ja) 2018-03-12 2023-10-20 コナゲン インコーポレイテッド ステビオール配糖体レバウジオシドｊ及びレバウジオシドｎの生合成による製造
JP7318989B2 (ja) * 2019-03-29 2023-08-01 コナゲン インコーポレイテッド Ｕｄｐ－ラムノースの生合成生産
CN112080480B (zh) * 2019-06-14 2023-01-03 中国科学院分子植物科学卓越创新中心 糖基转移酶突变体及其应用
US20240263152A1 (en) * 2021-06-01 2024-08-08 Abiochem Biotechnology Co., Ltd. Glycosyltransferase and application thereof
CN118489006A (zh) * 2021-12-24 2024-08-13 株式会社三养社 糖基转移酶变体和使用其制备甜菊糖苷的方法
WO2026101250A1 (ko) * 2024-11-06 2026-05-15 씨제이제일제당 (주) 신규한 당전이 효소 및 이의 용도
WO2026101249A1 (ko) * 2024-11-06 2026-05-15 씨제이제일제당 (주) 신규한 당전이 효소 및 이의 용도
CN119842657B (zh) * 2025-03-18 2025-05-27 青岛奔月生物技术有限公司 蔗糖合酶突变体及其应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016168413A1 (en) 2015-04-14 2016-10-20 Conagen Inc. Production of non-caloric sweeteners using engineered whole-cell catalysts
WO2017098017A1 (en) 2015-12-10 2017-06-15 Evolva Sa Production of steviol glycosides in recombinant hosts
US20170275666A1 (en) 2014-08-19 2017-09-28 The Coca-Cola Company Methods for Preparing Rebaudioside I and Uses
JP2017529857A (ja) 2014-10-03 2017-10-12 コナゲン インコーポレイテッド ノンカロリー甘味料および合成するための方法
JP2017532976A (ja) 2014-11-05 2017-11-09 マナス バイオシンセシス インコーポレイテッド ステビオール配糖体の微生物による生成
WO2018031955A2 (en) 2016-08-12 2018-02-15 Amyris, Inc. Udp-dependent glycosyltransferase for high efficiency production of rebaudiosides

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL128193A (en) * 1999-01-22 2008-03-20 Yeda Res & Dev Rhamnosyl-transferase gene and uses thereof
US20060143729A1 (en) * 2004-06-30 2006-06-29 Ceres, Inc. Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
US8791253B2 (en) * 2006-06-19 2014-07-29 The Coca-Cola Company Rebaudioside A composition and method for purifying rebaudioside A
AU2010267963B2 (en) * 2009-07-02 2015-09-24 Merz Pharma Gmbh & Co. Kgaa Neurotoxins exhibiting shortened biological activity
EP2742142B2 (en) * 2011-08-08 2020-03-25 Evolva SA Recombinant production of steviol glycosides
MX395285B (es) * 2012-05-22 2025-03-25 Purecircle Sdn Bhd Glucosidos de esteviol de alta pureza.
US9752174B2 (en) * 2013-05-28 2017-09-05 Purecircle Sdn Bhd High-purity steviol glycosides
CA2899276C (en) * 2013-02-06 2022-11-01 Evolva Sa Methods for improved production of rebaudioside d and rebaudioside m
US9522929B2 (en) 2014-05-05 2016-12-20 Conagen Inc. Non-caloric sweetener
WO2016036578A1 (en) * 2014-09-02 2016-03-10 Purecircle Sdn Bhd Stevia extracts
AU2016271125A1 (en) * 2015-05-29 2017-12-21 Cargill, Incorporated Heat treatment to produce glycosides
JP6771937B2 (ja) * 2016-04-21 2020-10-21 キヤノンメディカルシステムズ株式会社 医用画像表示装置および医用画像管理システム
JP7177048B2 (ja) * 2016-10-14 2022-11-22 コナゲン インコーポレイテッド ステビオール配糖体の生合成製造およびそのためのプロセス
WO2018072211A1 (zh) 2016-10-21 2018-04-26 苏州汉酶生物技术有限公司 一种酶法制备瑞鲍迪甙j的方法
JP7365707B2 (ja) 2018-03-12 2023-10-20 コナゲン インコーポレイテッド ステビオール配糖体レバウジオシドｊ及びレバウジオシドｎの生合成による製造
AU2019304965B2 (en) * 2018-07-16 2025-04-24 Manus Bio, Inc. Production of steviol glycosides through whole cell biotransformation
JP7318989B2 (ja) * 2019-03-29 2023-08-01 コナゲン インコーポレイテッド Ｕｄｐ－ラムノースの生合成生産
WO2020264179A1 (en) * 2019-06-25 2020-12-30 Manus Bio, Inc. Uridine diphosphate-dependent glycosyltransferase enzyme
EP4044823A4 (en) * 2019-10-16 2024-04-24 Sweegen, Inc. STEVIOL GLYCOSIDE FORMULATIONS FOR FOOD AND BEVERAGES

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170275666A1 (en) 2014-08-19 2017-09-28 The Coca-Cola Company Methods for Preparing Rebaudioside I and Uses
JP2017529857A (ja) 2014-10-03 2017-10-12 コナゲン インコーポレイテッド ノンカロリー甘味料および合成するための方法
JP2017532976A (ja) 2014-11-05 2017-11-09 マナス バイオシンセシス インコーポレイテッド ステビオール配糖体の微生物による生成
WO2016168413A1 (en) 2015-04-14 2016-10-20 Conagen Inc. Production of non-caloric sweeteners using engineered whole-cell catalysts
WO2017098017A1 (en) 2015-12-10 2017-06-15 Evolva Sa Production of steviol glycosides in recombinant hosts
WO2018031955A2 (en) 2016-08-12 2018-02-15 Amyris, Inc. Udp-dependent glycosyltransferase for high efficiency production of rebaudiosides

Also Published As

Publication number Publication date
BR112021021828A2 (pt) 2022-01-04
WO2019178116A1 (en) 2019-09-19
MX2021013721A (es) 2021-12-10
US11447808B2 (en) 2022-09-20
EP3997233A4 (en) 2023-08-23
US10883130B2 (en) 2021-01-05
US20200002742A1 (en) 2020-01-02
US20220411843A1 (en) 2022-12-29
WO2019178116A8 (en) 2019-10-10
EP3997233A1 (en) 2022-05-18
JP7305213B2 (ja) 2023-07-10
EP3765627A4 (en) 2021-10-13
WO2021007423A1 (en) 2021-01-14
US20200087695A1 (en) 2020-03-19
JP2021515555A (ja) 2021-06-24
US20210189448A1 (en) 2021-06-24
KR20210153670A (ko) 2021-12-17
JP2022540306A (ja) 2022-09-15
CN111868252B (zh) 2025-06-03
JP2023126903A (ja) 2023-09-12
CN111868252A (zh) 2020-10-30
US11441165B2 (en) 2022-09-13
EP3765627A1 (en) 2021-01-20

Similar Documents

Publication Publication Date Title
JP2023126903A (ja) ステビオール配糖体レバウジオシドｊ及びレバウジオシドｎの生合成による製造
JP7194111B2 (ja) ステビオール配糖体レバウジオシドｄ４のレバウジオシドｅからの生合成製造
JP7116751B2 (ja) β－グルコシダーゼによるステビオール配糖体の加水分解
AU2018220068A1 (en) Methods for improved production of rebaudioside D and rebaudioside M
US20220205007A1 (en) Biosynthetic production of steviol glycoside rebaudioside i via variant enzymes
HK40018024A (en) Hydrolysis of steviol glycosides by beta -glucosidase
HK1230659A1 (en) Recombinant production of steviol glycosides

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220126

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230116

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230407

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230615

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230704

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230920

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231002

R150 Certificate of patent or registration of utility model

Ref document number: 7365707

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150